Suggests clinical trial results published in todays online edition of The Lancet

ACD CPR performed with mix of ResQPump and ResQPOD could save lives of cardiac arrest sufferers A combination of two products could save the lives of a large number of cardiac arrest patients each year if applied nationwide, suggests clinical trial results published in today’s online edition of The Lancet. Both gadgets are manufactured by Advanced Circulatory Systems, Inc. in Roseville, Minn . Dr. Tom P. Aufderheide, Professor of Emergency Medication at the Medical College of Wisconsin in Milwaukee was initially author and a principal investigator at one of the study sites. ‘The goal of resuscitation during cardiac arrest is usually long-term survival with preservation of brain function,’ commented Dr. Aufderheide. ‘This fresh, effective intervention achieves that objective and is potentially the most significant advancement in the treatment of cardiac arrest since defibrillation.’ Ralph J.

The American Brain Tumor Association Study Awards Program will once again offer Basic Research Fellowship and Translational Research Grant awards for 2009-2010. PRELIMINARY RESEARCH Fellowships are two-year, $80,000 schooling awards that support youthful researchers entering the field of mind tumor research. Twelve months, $75,000 Translational Grants help scientists to further develop research that’s on the cusp of shifting from the laboratory into individual testing. PRELIMINARY RESEARCH Fellowship and Translational grant applications will post at the ABTA site, in the study Progress section, by October15th. Applications for these awards are due no afterwards than January 8, 2010..